Kite Pharma
Biotechnology company developing and commercializing cell therapies for cancer treatment.
About
Kite Pharma is a biotechnology company focused on developing and commercializing innovative cancer immunotherapy products, primarily through genetically engineered autologous CAR T cell therapy. Founded in 2009, it was acquired by Gilead Sciences in 2017 and operates as a subsidiary dedicated to advancing personalized treatments in immuno-oncology. Teams look it up for Biotechnology, Pharmaceuticals, Oncology.
Frequently asked
What does Kite Pharma do?
Kite Pharma is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Oncology, Cell Therapy. It is based in Santa Monica, United States and was founded in 2009. Public records show $421M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Kite Pharma raised?
Kite Pharma has raised a total of $421M in funding. The most recent round on record is Venture.
Where is Kite Pharma headquartered?
Kite Pharma is headquartered in Santa Monica, United States.
When was Kite Pharma founded?
Kite Pharma was founded in 2009.
What industry does Kite Pharma operate in?
Kite Pharma operates in Biotechnology, Pharmaceuticals, Oncology, Cell Therapy.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.